Related Experiment Video
Updated: Aug 5, 2025

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
Mutations in the B30.2 and the central helical scaffold domains of pyrin differentially affect inflammasome
Daria Chirita1, Pauline Bronnec1, Flora Magnotti1
1CIRI, Centre International de Recherche en Infectiologie, Univ Lyon, Inserm U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007, LYON, France.
Abstract:
Familial Mediterranean Fever (FMF) is the most common monogenic autoinflammatory disorder. FMF is caused by mutations in the MEFV gene, encoding pyrin, an inflammasome sensor. The best characterized pathogenic mutations associated with FMF cluster in exon 10. Yet, mutations have been described along the whole MEFV coding sequence. Exon 10 encodes the B30.2 domain of the pyrin protein, but the function of this human-specific domain remains unclear. Pyrin is an inflammasome sensor detecting RhoA GTPase inhibition following exposure to bacterial toxins such as TcdA. Here, we demonstrate that the B30.2 domain is dispensable for pyrin inflammasome activation in response to this toxin. Deletion of the B30.2 domain mimics the most typical FMF-associated mutation and confers spontaneous inflammasome activation in response to pyrin dephosphorylation. Our results indicate that the B30.2 domain is a negative regulator of the pyrin inflammasome that acts independently from and downstream of pyrin dephosphorylation. In addition, we identify the central helical scaffold (CHS) domain of pyrin, which lies immediately upstream of the B30.2 domain as a second regulatory domain. Mutations affecting the CHS domain mimic pathogenic mutations in the B30.2 domain and render the pyrin inflammasome activation under the sole control of the dephosphorylation. In addition, specific mutations in the CHS domain strongly increase the cell susceptibility to steroid catabolites, recently described to activate pyrin, in both a cell line model and in monocytes from genotype-selected FMF patients. Taken together, our work reveals the existence of two distinct regulatory regions at the C-terminus of the pyrin protein, that act in a distinct manner to regulate positively or negatively inflammasome activation. Furthermore, our results indicate that different mutations in pyrin regulatory domains have different functional impacts on the pyrin inflammasome which could contribute to the diversity of pyrin-associated autoinflammatory diseases.
Insights
Familial Mediterranean Fever (FMF) is linked to MEFV gene mutations. This study reveals the B30.2 domain negatively regulates pyrin inflammasome activation, and the CHS domain also impacts this process, explaining disease diversity.
Area of Science:
- Molecular Biology
- Immunology
- Genetics
Background:
- Familial Mediterranean Fever (FMF) is a common monogenic autoinflammatory disorder caused by mutations in the MEFV gene, which encodes pyrin.
- Pathogenic mutations often cluster in exon 10, encoding the B30.2 domain, but its precise function in pyrin regulation is unclear.
- Pyrin functions as an inflammasome sensor, activated by RhoA GTPase inhibition, notably by bacterial toxins like TcdA.
Purpose of the Study:
- To investigate the role of the B30.2 domain in pyrin inflammasome activation.
- To identify other regulatory domains within the pyrin protein.
- To understand how mutations in these domains contribute to FMF pathogenesis and disease diversity.
Main Methods:
- Deletion of the B30.2 domain in pyrin.
- Assessing pyrin inflammasome activation following dephosphorylation.
- Investigating mutations in the central helical scaffold (CHS) domain.
- Evaluating cellular responses to steroid catabolites in cell lines and FMF patient monocytes.
Main Results:
- The B30.2 domain is dispensable for TcdA-induced inflammasome activation but acts as a negative regulator.
- Deletion of the B30.2 domain leads to spontaneous inflammasome activation upon pyrin dephosphorylation.
- The CHS domain is identified as a second regulatory region; mutations here mimic B30.2 mutations and dysregulate inflammasome activation.
- Specific CHS domain mutations increase susceptibility to steroid catabolites, impacting FMF patient monocytes.
Conclusions:
- The C-terminus of pyrin contains two distinct regulatory domains: B30.2 (negative regulator) and CHS (involved in regulation and steroid catabolite response).
- These domains modulate inflammasome activation differently, impacting disease mechanisms.
- Understanding these regulatory domains and mutation impacts is crucial for explaining the diverse clinical manifestations of pyrin-associated autoinflammatory diseases.
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
The JAK-STAT Signaling Pathway

